Department of Cardiac Surgery, Shaare Zedek Medical Center, Jerusalem, Israel.
Department of Cardiac Surgery, Shaare Zedek Medical Center, Jerusalem, Israel.
Ann Thorac Surg. 2018 Feb;105(2):581-586. doi: 10.1016/j.athoracsur.2017.07.033. Epub 2017 Nov 11.
The neutrophil-lymphocyte ratio (NLR) is a recognized marker of inflammation associated with poor outcomes in various clinical situations. We analyzed the prognostic significance of preoperative elevated NLR in patients undergoing cardiac surgery.
We performed a retrospective review of 3,027 consecutive patients undergoing cardiac surgery. Receiver-operating-characteristic was used to determine the cutoff value for elevated NLR. Multivariate regression was used to determine the predictive value of preoperative NLR on clinical outcomes. Cox proportional hazards functions were used to determine predictors of late events. Late survival data to 16 years was obtained from the Ministry of Interior.
The cutoff value for elevated NLR was 2.6. Patients with elevated NLR were older (p < 0.0001), had a higher incidence of cardiac comorbidity (p < 0.0001), and higher European System for Cardiac Operative Risk Evaluation score (p < 0.0001). An elevated NLR emerged as an independent predictor of operative mortality (hazard ratio [HR] 2.15, 95% confidence interval [CI]: 1.51 to 3.08, p < 0.0001); pleural effusion (HR 1.42, 95% CI: 1.13 to 1.80, p = 0.003); low output syndrome (HR 1.54, 95% CI: 1.23 to 1.93, p = 0.0002); prolonged ventilation (HR 1.49, 95% CI: 1.23 to 1.82, p = 0.0001); or composite outcomes (HR 1.61, 95% CI: 1.36 to 1.91, p < 0.0001). The NLR emerged as an independent predictor of late mortality (HR 1.19, 95% CI: 1.11 to 1.28; p < 0.0001).
Elevated NLR is associated with a higher incidence of adverse outcomes after cardiac surgery. It is a predictor of operative as well as late mortality. Further studies are warranted to determine whether prophylactic treatment with antiinflammatory agents can prevent such outcomes. It may be warranted to include the baseline NLR as another variable in risk stratification of patients about to undergo cardiac surgery.
中性粒细胞与淋巴细胞比值(NLR)是一种公认的炎症标志物,与各种临床情况下的不良预后相关。我们分析了术前 NLR 升高对接受心脏手术患者的预后意义。
我们对 3027 例连续接受心脏手术的患者进行了回顾性分析。使用受试者工作特征(ROC)确定 NLR 升高的截断值。多变量回归用于确定术前 NLR 对临床结局的预测价值。Cox 比例风险函数用于确定晚期事件的预测因素。从内政部获得了 16 年的晚期生存数据。
NLR 升高的截断值为 2.6。NLR 升高的患者年龄较大(p<0.0001),心脏合并症发生率较高(p<0.0001),欧洲心脏手术风险评估系统评分较高(p<0.0001)。NLR 升高是手术死亡率的独立预测因素(危险比 [HR] 2.15,95%置信区间 [CI]:1.51 至 3.08,p<0.0001);胸腔积液(HR 1.42,95% CI:1.13 至 1.80,p=0.003);低心输出综合征(HR 1.54,95% CI:1.23 至 1.93,p=0.0002);延长通气时间(HR 1.49,95% CI:1.23 至 1.82,p=0.0001);或复合结局(HR 1.61,95% CI:1.36 至 1.91,p<0.0001)。NLR 升高是晚期死亡率的独立预测因素(HR 1.19,95% CI:1.11 至 1.28;p<0.0001)。
NLR 升高与心脏手术后不良结局的发生率增加相关。它是手术和晚期死亡率的预测因素。需要进一步的研究来确定预防性使用抗炎药物是否可以预防此类结局。将基线 NLR 作为即将接受心脏手术的患者风险分层的另一个变量可能是合理的。